Table of Contents
ISRN Pain
Volume 2014, Article ID 915464, 7 pages
http://dx.doi.org/10.1155/2014/915464
Research Article

Antinociceptive Effects of the Serotonin and Noradrenaline Reuptake Inhibitors Milnacipran and Duloxetine on Vincristine-Induced Neuropathic Pain Model in Mice

1Department of Clinical Pharmaceutics, Tohoku Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan
2Department of Pharmacology, Daiichi College of Pharmaceutical Sciences, 22-1 Tamagawa-cho, Minami-ku, Fukuoka 815-8511, Japan

Received 24 December 2013; Accepted 14 January 2014; Published 23 February 2014

Academic Editors: D. Balayssac, C. Courteix, J. Ferreira, M. Takeda, and M. Tsuruoka

Copyright © 2014 Soh Katsuyama et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. M. Dougherty, J. P. Cata, A. W. Burton, K. Vu, and H.-R. Weng, “Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain,” Journal of Pain and Symptom Management, vol. 33, no. 2, pp. 166–179, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. T. J. Postma, B. A. Benard, P. C. Huijgens, G. J. Ossenkoppele, and J. J. Heimans, “Long term effects of vincristine on the peripheral nervous system,” Journal of Neuro-Oncology, vol. 15, no. 1, pp. 23–27, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Quasthoff and H. P. Hartung, “Chemotherapy-induced peripheral neuropathy,” Journal of Neurology, vol. 249, no. 1, pp. 9–17, 2002. View at Google Scholar · View at Scopus
  4. J. A. Micó, D. Ardid, E. Berrocoso, and A. Eschalier, “Antidepressants and pain,” Trends in Pharmacological Sciences, vol. 27, no. 7, pp. 348–354, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Rogawski and W. Löscher, “The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions,” Nature Medicine, vol. 10, no. 7, pp. 685–692, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Dharmshaktu, V. Tayal, and B. S. Kalra, “Efficacy of antidepressants as analgesics: a review,” Journal of Clinical Pharmacology, vol. 52, no. 1, pp. 6–17, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. E. M. Smith, H. Pang, C. Cirrincione et al., “Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial,” The Journal of the American Medical Association, vol. 309, no. 13, pp. 1359–1367, 2013. View at Google Scholar
  8. D. Mochizucki, “Serotonin and noradrenaline reuptake inhibitors in animal models of pain,” Human Psychopharmacology, vol. 19, supplement 1, pp. S15–S19, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Yokogawa, Y. Kiuchi, Y. Ishikawa et al., “An investigation of monoamine receptors involved in antinociceptive effects of antidepressants,” Anesthesia and Analgesia, vol. 95, no. 1, pp. 163–168, 2002. View at Google Scholar · View at Scopus
  10. T. Ikeda, Y. Ishida, R. Naono et al., “Effects of intrathecal administration of newer antidepressants on mechanical allodynia in rat models of neuropathic pain,” Neuroscience Research, vol. 63, no. 1, pp. 42–46, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Obata, S. Saito, S. Koizuka, K. Nishikawa, and F. Goto, “The monoamine-mediated antiallodynic effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a rat model of neuropathic pain,” Anesthesia and Analgesia, vol. 100, no. 5, pp. 1406–1410, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Suzuki, K. Ueta, S. Tamagaki, and T. Mashimo, “Antiallodynic and antihyperalgesic effect of milnacipran in mice with spinal nerve ligation,” Anesthesia and Analgesia, vol. 106, no. 4, pp. 1309–1315, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Katsuyama, K. Sato, T. Yagi, Y. Kishikawa, and H. Nakamura, “Effects of repeated milnacipran and fluvoxamine treatment on mechanical allodynia in a mouse paclitaxel-induced neuropathic pain model,” Journal of Biomedical Research, vol. 34, no. 2, pp. 105–111, 2013. View at Google Scholar
  14. A. Önal, A. Parlar, and S. Ülker, “Milnacipran attenuates hyperalgesia and potentiates antihyperalgesic effect of tramadol in rats with mononeuropathic pain,” Pharmacology Biochemistry and Behavior, vol. 88, no. 2, pp. 171–178, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. D. J. Goldstein, Y. Lu, M. J. Detke, T. C. Lee, and S. Iyengar, “Duloxetine vs. placebo in patients with painful diabetic neuropathy,” Pain, vol. 116, no. 1-2, pp. 109–118, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Raskin, Y. L. Pritchett, F. Wang et al., “A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain,” Pain Medicine, vol. 6, no. 5, pp. 346–356, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. J. F. Wernicke, Y. L. Pritchett, D. N. D'Souza et al., “A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain,” Neurology, vol. 67, no. 8, pp. 1411–1420, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Iyengar, A. A. Webster, S. K. Hemrick-Luecke, J. Y. Xu, and R. M. A. Simmons, “Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats,” Journal of Pharmacology and Experimental Therapeutics, vol. 311, no. 2, pp. 576–584, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. C. K. Jones, B. J. Eastwood, A. B. Need, and H. E. Shannon, “Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition,” Neuropharmacology, vol. 51, no. 7-8, pp. 1172–1180, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. C. K. Jones, S. C. Peters, and H. E. Shannon, “Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents,” Journal of Pharmacology and Experimental Therapeutics, vol. 312, no. 2, pp. 726–732, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. C. K. Jones, S. C. Peters, and H. E. Shannon, “Synergistic interactions between the dual serotonergic, noradrenergic reuptake inhibitor duloxetine and the non-steroidal anti-inflammatory drug ibuprofen in inflammatory pain in rodents,” European Journal of Pain, vol. 11, no. 2, pp. 208–215, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Mixcoatl-Zecuatl and C. G. Jolivalt, “A spinal mechanism of action for duloxetine in a rat model of painful diabetic neuropathy,” British Journal of Pharmacology, vol. 164, no. 1, pp. 159–169, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Munro, “Pharmacological assessment of the rat formalin test utilizing the clinically used analgesic drugs gabapentin, lamotrigine, morphine, duloxetine, tramadol and ibuprofen: Influence of low and high formalin concentrations,” European Journal of Pharmacology, vol. 605, no. 1-3, pp. 95–102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Zimmermann, “Ethical guidelines for investigations of experimental pain in conscious animals,” Pain, vol. 16, no. 2, pp. 109–110, 1983. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Kiguchi, T. Maeda, Y. Kobayashi, T. Kondo, M. Ozaki, and S. Kishioka, “The critical role of invading peripheral macrophage-derived interleukin-6 in vincristine-induced mechanical allodynia in mice,” European Journal of Pharmacology, vol. 592, no. 1–3, pp. 87–92, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Obata, M. Kimura, K. Nakajima, M. Tobe, K. Nishikawa, and S. Saito, “Monoamine-dependent, opioid-independent antihypersensitivity effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a postoperative pain model in rats,” Journal of Pharmacology and Experimental Therapeutics, vol. 334, no. 3, pp. 1059–1065, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. D. A. Fishbain, R. Cutler, H. L. Rosomoff, and R. S. Rosomoff, “Evidence-based data from animal and human experimental studies on pain relief with antidepressants: a structured review,” Pain Medicine, vol. 1, no. 4, pp. 310–316, 2000. View at Google Scholar · View at Scopus
  28. K. Nakajima, H. Obata, N. Iriuchijima, and S. Saito, “An increase in spinal cord noradrenaline is a major contributor to the antihyperalgesic effect of antidepressants after peripheral nerve injury in the rat,” Pain, vol. 153, no. 5, pp. 990–997, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Ma and J. C. Eisenach, “Chronic constriction injury of sciatic nerve induces the up-regulation of descending inhibitory noradrenergic innervation to the lumbar dorsal horn of mice,” Brain Research, vol. 970, no. 1-2, pp. 110–118, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Xu, W.-S. Zhang, J.-L. Yang, H. Xu, X.-M. Deng, and Y.-Q. Zhang, “Dexmedetomidine blocks thermal hyperalgesia and spinal glial activation in rat model of monoarthritis,” Acta Pharmacologica Sinica, vol. 31, no. 5, pp. 523–530, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. E. D. Milligan and L. R. Watkins, “Pathological and protective roles of glia in chronic pain,” Nature Reviews Neuroscience, vol. 10, no. 1, pp. 23–36, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Ren and R. Dubner, “Interactions between the immune and nervous systems in pain,” Nature Medicine, vol. 16, no. 11, pp. 1267–1276, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. X. T. Ji, N. S. Qian, T. Zhang et al., “Spinal astrocytic activation contributes to mechanical allodynia in a rat chemotherapy-induced neuropathic pain model,” PLoS One, vol. 8, no. 4, Article ID e60733, 2013. View at Google Scholar
  34. M. Inazu, H. Takeda, and T. Matsumiya, “Expression and functional characterization of the extraneuronal monoamine transporter in normal human astrocytes,” Journal of Neurochemistry, vol. 84, no. 1, pp. 136–144, 2003. View at Publisher · View at Google Scholar · View at Scopus